Excipial

Carbamide Peroxide

Treatment option:

Medically reviewed

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Excipial

Quick Facts about Excipial (Carbamide Peroxide)

Property	Description
Active ingredient	Carbamide Peroxide (Urea hydrogen peroxide)
Form	Otic Solution (Ear Drops)
Pharmacological Class	Cerumenolytic Agent
General Purpose	Softening and loosening impacted ear wax
Origin	Synthetic Compound

What Type of Medicine is Excipial and What is its Core Purpose?

Excipial, specifically in its formulation containing Carbamide Peroxide, is defined as an Otic Solution, a non-prescription liquid preparation for auricular use. Its fundamental classification is as a Cerumenolytic Agent, an established class of medication designed to soften and remove ear wax. Its essential purpose is to address the discomfort and symptoms, such as the feeling of aural fullness or muffled hearing, caused by excessive or hardened ear wax (cerumen).

This product is distinct from preparations that manage pain or infection, focusing exclusively on the physical and chemical disruption of the wax. This class of agent is used to aid in the removal of ear wax, positioning it as a preliminary home treatment for common wax buildup.

Carbamide Peroxide: Composition and Active Ingredient

The medicine's action is governed by its single active ingredient, Carbamide Peroxide (Urea hydrogen peroxide), which is a synthetic compound. This active substance is dissolved in a viscous vehicle, typically Anhydrous Glycerin, which acts as the carrier to ensure optimal contact with the wax. The inclusion of Glycerin provides a key functional characteristic, ensuring the solution remains in contact with the dense, impacted cerumen, which is necessary for the chemical reaction to begin.

How Does Excipial Generally Relieve Ear Wax Impaction?

The mechanism of relief is a localized, dual-phase process. The Carbamide Peroxide decomposes upon contact with moisture, releasing hydrogen peroxide and nascent oxygen. This chemical event generates a mild, effervescent (foaming) action directly against the accumulated cerumen.

This combination of effects provides the general benefit: the chemical process rapidly softens the dense wax, while the physical mechanical effervescence gently lifts and separates the wax from the ear canal lining. This non-invasive action is instrumental in mobilizing the impacted material, preparing it for subsequent clearance.

Regulatory References

National Institutes of Health

What side effects are possible with Excipial?

Possible side effects and safety information

The safety profile for topical urea preparations, such as Excipial, is primarily characterized by effects classified under Skin and Subcutaneous Tissue Disorders. These classifications are based on official regulatory documentation and post-marketing surveillance data, following a standardized frequency framework.

Adverse Reactions and Frequency Classification

The majority of documented adverse reactions are local, affecting the site of application. Regulatory documents categorize these effects by frequency:

Common Reactions (occurring in 1 to 10 individuals out of 100) include a stinging sensation, burning sensation, local irritation, pruritus (itching), and erythema (redness).
Uncommon Reactions (occurring in 1 to 10 individuals out of 1,000) may include localized rash, desquamation (flaky skin peeling off), or papule formation.

Serious Adverse Reactions and Safety Constraints

While uncommon, the possibility of serious allergic reactions (hypersensitivity) is officially documented under Immune System Disorders. These reactions may manifest as severe generalized rash, hives, or swelling. Severe local changes, such as blistering or crusting of the treated skin, are also considered clinically significant reactions to report.

Safety Restrictions: The official safety profile includes explicit contraindications that restrict use. The preparation should not be used by individuals with a known hypersensitivity to any of its components. Furthermore, application is generally contraindicated on broken skin, inflamed skin, fissures, or in the presence of an acute viral skin disease or skin infection. The common local reactions are typically temporary and often more noticeable upon initial application, with resolution expected upon cessation of treatment.

Overdose and Emergency Response

The regulatory overdose profile for Excipial (Carbamide Peroxide Otic Solution) is defined primarily by the risks associated with accidental ingestion or exposure to non-target tissue, as overdose from typical otic use is not generally expected to be dangerous.

Documented Manifestations and Severe Outcomes

Accidental swallowing of the solution may result in local tissue damage, including burns to the mouth, esophagus, or stomach, especially with large volumes or higher concentrations. Acute signs of overdose can include stomach upset, vomiting, or throat irritation. A rare, but life-threatening, toxicity involves the potential formation of a gas embolism, a condition that may manifest as difficulty breathing, chest pain, or confusion.

Mandated Emergency Actions

Regulatory labeling mandates seeking emergency medical attention immediately if the solution is accidentally swallowed. If an individual has ingested the solution and is experiencing serious symptoms such as trouble breathing or loss of consciousness, emergency services (911) must be contacted immediately. For accidental contact with the eyes, the mandated procedure is to flush the eyes with water for an extended period and consult a doctor. Specific regulatory guidance notes that use in children under 12 years of age should be under the direction of a health care provider. No specific antidote is described in the official labeling; management is supportive.

Therapeutic Uses of Excipial

What Excipial Treats: Main Uses and Benefits

Excipial is utilized for the supportive management of dry skin and conditions associated with an impaired skin barrier function. The primary therapeutic benefit is to offer symptomatic relief from the discomforts linked to cutaneous dryness, while supporting the maintenance of skin comfort and healthy appearance.

Therapeutic Applications

The preparation is appropriate for managing symptoms in various common scenarios, including general skin roughness, chapping, mild forms of dermatitis, and xerosis (abnormally dry skin). Its application helps to address dryness arising from environmental factors such as cold exposure or frequent cleansing. By assisting the skin’s moisture retention capacity, Excipial contributes to soothing the skin and promoting the suppleness of affected areas.

The use of moisturizing preparations aligns with established dermatological practice for dry skin treatment.

Quick Facts

Quick Fact: Relief for Persistent Dryness
- Excipial supports the skin barrier, contributing to the relief of discomfort associated with persistent, chronic skin dryness.

Regulatory References

NIH MedlinePlus guidance on dry skin treatment

Eligibility and Restrictions for Use

Who Can and Cannot Use Excipial?

The official regulatory profile for Excipial (urea-based cream/lotion) defines eligibility based on hypersensitivity, physiological status, and application site.

Contraindicated Populations

Use of Excipial is formally contraindicated in patients with a known hypersensitivity to any of the product's listed ingredients. This is an absolute non-eligibility rule.

Populations Requiring Restricted or Conditional Use

Target Population: The product is officially indicated for use by the adult population seeking treatment for hyperkeratotic conditions such as xerosis and eczema.
Pregnancy Status: For pregnant women, use is restricted to being only if clearly needed, due to a lack of adequate and well-controlled studies.
Lactation: Caution should be exercised when administered to a nursing mother, as regulatory data does not confirm drug excretion in human milk.

Age and Condition Rules

Official labeling does not define specific restrictions based on the status of a patient’s hepatic (liver) or renal (kidney) function. Similarly, no specific restrictions are documented for the pediatric or older adult (geriatric) populations. The product is strictly for topical use only and application must avoid contact with the eyes, lips, and mucous membranes.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes the officially documented interaction profile for Excipial (Carbamide Peroxide Otic Solution) based on government regulatory sources.

Interaction Scope and Profile

Category	Regulatory Status
Systemic Drug-Drug Interactions	None documented. Official regulatory labeling for Carbamide Peroxide Otic Solution formally states there are no known systemic interactions.
Metabolic/Enzyme Interactions	None documented. The product’s minimal systemic absorption prevents the risk of altering the metabolism (e.g., CYP450) of co-administered systemic medicines.
Timing-based Separation	Not applicable. Regulatory documents do not mandate time separation for co-administering oral or injectable medications.
Food, Alcohol, or Supplements	None documented. Official labeling contains no information on interactions with ingested substances.
Local Co-administration	Restricted. Caution is noted against the concurrent use of other preparations intended for application in the ear canal (otic products).

Official Interaction Summary

Official regulatory documents define the product's interaction structure primarily through the absence of systemic interaction data. Due to its strictly localized effect, the label contains no documented interaction mechanisms related to drug transporters, metabolic enzymes, or altered systemic exposure (AUC/Cmax) of other medicines. The only specific restriction involves the site of administration, noting a caution against co-administering the solution with other ear-applied products.

Mechanism of Action

The action of Excipial (Carbamide Peroxide) is a localized chemo-mechanical process that directly targets the hardened structure of the ear wax (cerumen) rather than engaging systemic biological receptors or pathways.

Localized Chemo-Mechanical Disruption

This domain covers the primary chemical breakdown and the resulting physical force applied to the cerumen. The active ingredient rapidly decomposes upon contact with moisture, releasing nascent oxygen ( O2) gas. This release causes a distinct effervescence that physically fragments and separates the impacted cerumen mass, initiating dislodgement from the canal wall.

Structural Hydration and Softening

This domain describes the chemical softening of the cerumen's solid matrix. The decomposition also yields Urea and Water, which act together as a mild keratolytic and hygroscopic system. These byproducts penetrate the cerumen structure, hydrating and swelling the protein-rich components (keratin), which significantly reduces the wax's rigidity and cohesion, facilitating disintegration and subsequent dislodgement.

Dosage and Administration Information

How Excipial is Used: Administration Guidelines

Excipial products have two primary administration routes and usage patterns, defined by their active ingredient and purpose.

Administration Scope: Otic Solution (Carbamide Peroxide 6.5%)

Feature	Usage Principle
Route of Administration	Auricular (instilled into the ear canal).
Standard Dosing	5 to 10 drops in the affected ear(s).
Frequency & Duration	Twice daily for a maximum of four consecutive days.
Age-Group Rule	Standard dose for adults and children over 12 years of age. Use in children under 12 requires a physician's consultation.
Procedural Technique	The head must be tilted sideways during instillation, and the dropper tip is not permitted to enter the ear canal. The drops should be kept in the ear for several minutes. Following treatment, gentle flushing of the ear with warm water may be performed.

Administration Scope: Topical Preparations (Urea Lotions/Creams)

Feature	Usage Principle
Route of Administration	Topical (applied directly to the skin).
Standard Dosing	Applied in a thin, suitable layer to the affected area.
Frequency Pattern	Typically applied two to three times a day.
Usage Context	Often used as part of a long-term plan for managing chronic skin dryness. The preparation is applied to areas that are clean and dry, avoiding mucous membranes and broken skin.

These instructions define the distinct methods, amounts, and time limits for administration, standardizing the approach to using the preparation.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Excipial (Urea-based Emollient)

Research Evidence for Managing Dry Skin and Skin Barrier Function

Research exploring the supportive role of this urea-based emollient for general dry skin (xerosis cutis) has included Randomized Controlled Trials (RCTs). These studies were structured to compare the preparation against controls over short periods. Researchers were interested in how research tracked outcomes related to physical discomfort as well as objective measures like Transepidermal Water Loss (TEWL), which is used in research to help assess the function of the skin barrier. Trials monitored symptoms in the observed populations, specifically looking at clinical grading of features like scaling and roughness.

Research monitored measurements related to skin hydration during the study period. Findings describe patterns observed in biophysical assessments, and the evidence contributes to understanding symptom patterns in conditions marked by functional limitations of the skin, such as Ichthyosis Vulgaris, which was observed in some studies.

Evidence for Supportive Care in Atopic Dermatitis

Studies were conducted during periods of increased symptom activity in individuals with Atopic Dermatitis (eczema). Research examined changes in Disease Severity Scores (like SCORAD or EASI) and also monitored the patients' use of other topical medications, such as Topical Corticosteroids. Systematic analyses of these trials report how studies monitored symptoms in the observed populations. Evidence suggests a role for the preparation in research exploring how symptoms change over time when used as part of a general skin care regimen.

Research on Relapse Prevention

Studies monitored populations over defined time intervals, with some follow-up durations extending up to six months, to examine outcomes related to episodic or acute changes. Research has explored the potential of the preparation to influence the duration of stability between periods of heightened symptom activity. Findings describe patterns observed in studies related to time to flare and relapse rates in the observed populations.

What the Research Landscape Shows: Gaps and Uncertainties

Evidence highlights what is known—and what is still uncertain—about this preparation. While a body of research exists, the certainty remains low for some outcomes, and the evidence quality varies across studies. The follow-up durations were limited in many of the core trials investigating xerosis. Subgroup findings are uncertain, and data for certain patient groups, especially very young children or those with specific comorbidities, remain insufficient.

Frequently Asked Questions (FAQ)

Common questions about Excipial (FAQ)

Q: Does Excipial cause photosensitivity or sun issues?

Official product information suggests that Excipial preparations, like many emollients, do not typically cause photosensitivity. General recommendations often include protecting skin from excessive sun exposure, particularly if the skin is irritated or damaged.

Q: Can I use Excipial on my face, and is it non-comedogenic?

Regulatory documents indicate that certain Excipial products are developed for facial skin, especially those formulated as lighter lotions or creams. While the term 'non-comedogenic' may not appear on all regulatory labels, the preparations are developed to be suitable for use on various skin areas.

Q: Is Excipial safe to use during pregnancy or breastfeeding?

According to official product information, Excipial preparations, being topical emollients, are generally considered safe for use during pregnancy and while breastfeeding. Official information suggests avoiding application directly to the breast area immediately prior to nursing.

Q: What is the main purpose of Excipial?

The main purpose of Excipial, as stated in regulatory documents, is to treat and soothe dry skin conditions such as eczema (atopic dermatitis) and other forms of dermatitis. It functions by providing the skin with moisture and essential lipids, which helps to support the skin’s natural protective barrier.

Q: Are there different strengths or types of Excipial?

Yes, official product information indicates that Excipial is available in various formulations that offer different concentrations of lipid (oil) and water content. These types range from lighter lotions to richer creams and ointments, allowing for selection based on the individual's degree of skin dryness.

Q: How long can I use Excipial before seeing results?

The time to see results can vary depending on the severity of the initial skin condition. Experience of results can vary; noticeable improvement in dryness and associated symptoms is commonly reported following a few days to a week of consistent application.

How should Excipial be stored and disposed of?

How to Store and Dispose of Excipial?

The storage conditions for Excipial (dermatological preparation) are strictly defined to maintain its stability. Regulatory guidance requires storing the product below 30°C and explicitly prohibits refrigeration or freezing. The container must be kept tightly closed in its original package and protected from direct sunlight.

Storage Summary

Condition	Requirement (Official Labeling)
Temperature	Store below 30 C. Do not freeze or refrigerate.
Container	Keep tightly closed in the original package.

All medicines must be stored out of the sight and reach of children. Unused or expired Excipial should be disposed of via an authorized drug take-back program or by following specific household trash procedures; disposal by flushing down the toilet is generally prohibited.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Lithuania

Slovakia

Turkey

A-Z Index:

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z